Skip to main content

Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

A CME/CE-certified, MOC-eligible Activity

Click here to complete your registration.

Tuesday, September 15, 2020
4:00 – 5:00 PM ET (8:00 – 9:00 PM GMT / 3:00 – 4:00 PM CT / 1:00 – 2:00 PM PT)

Tuesday, September 29, 2020
1:00 – 2:00 PM ET (5:00 – 6:00 PM GMT / 12:00 Noon – 1:00 PM CT / 10:00 – 11:00 AM PT)

Thursday, October 15, 2020
7:00 – 8:00 PM ET (11:00 PM – 12:00 AM GMT / 6:00 – 7:00 PM CT / 4:00 – 5:00 PM PT)

Welcome and Introduction
Understanding the Pathophysiology of COVID-19
Recognizing the Risk of COVID-19 in Patients with Lung Cancer
Managing Patients with Lung Cancer During the COVID-19 Pandemic

- Considerations for managing medication
- Distinguishing between COVID-19 and interstitial lung disease and pneumonitis
- Managing patients with lung cancer who are COVID-19 positive
Q&A Session and Concluding Remarks

Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine requires special attention, particularly because symptoms of COVID-19 infection are similar to common adverse events associated with lung cancer treatment.

This activity, “Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide clinicians with the most up-to-date guidance on managing lung cancer during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in patients with lung cancer, and strategies to manage patient care and counsel through telemedicine.

Sandra Cuellar, PharmD, BCOP
Associate Professor
University of Illinois at Chicago College of Pharmacy
Clinical Oncology Pharmacist, UI Health
Chicago, IL

J. Morgan Freiman, MD, MSc
Infectious Diseases Physician
Director of Antimicrobial Stewardship
Lahey Hospital and Medical Center
Assistant Professor of Medicine
Tufts University School of Medicine
Boston, MA

Antonio Passaro, MD, PhD
Division of Thoracic Oncology
European Institute of Oncology
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Milan, Italy

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA

Terufumi Kato, MD
Chief Physician
Department of Thoracic Oncology
Kanagawa Cancer Center
Yokohama, Japan


The intended audience for this educational initiative is clinicians responsible for the daily management of patients with lung cancers.

This program is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.

This program is designed to address ACPE competencies, including foundational knowledge and essentials for practice and care.

At the conclusion of this education, participants should be able to:
  • Discuss the most current understanding of the pathophyisiology of COVID-19
  • Recognize and evaluate factors that increase risk of COVID-19 among patients with lung cancer
  • Integrate consensus recommendations for the safe and effective management of patients with lung cancer during the COVID-19 pandemic
  • Provide counsel to patients with lung cancer regarding concerns or fears related to COVID-19

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the CME accreditation of this activity, please email:


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through BUSM’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-20-005-L01-P).

This is a knowledge-based activity.

For information about this continuing pharmacy education (CPE) activity, please email:

This nursing continuing professional development activity was approved by the Maryland Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

These materials and all other materials provided in conjunction with continuing medical education activities are intended solely for purposes of supplementing continuing medical education programs for qualified health care professionals. Anyone using the materials assumes full responsibility and all risk for their appropriate use. Trustees of Boston University makes no warranties or representations whatsoever regarding the accuracy, completeness, currentness, noninfringement, merchantability or fitness for a particular purpose of the materials. In no event will trustees of Boston University be liable to anyone for any decision made or action take in reliance on the materials. In no event should the information in the materials be used as a substitute for professional care.

This educational activity has been produced in adherence with the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Disclosures will be made known to the participants prior to the start of the activity.

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

To ensure your computer is compatible for the live event, please perform a system check by clicking on the link or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.

  • 1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
  • Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
  • 512 MB of RAM (1 GB recommended)
  • Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)
  • 1.83 GHz Intel Core Duo or faster processor
  • 512 MB RAM (1 GB recommended)
  • Mac OS X 10.12, 10.13 and 10.14
  • Mozilla Firefox, Apple Safari, Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)
  • The Adobe Connect app for iOS and Android requires Adobe Connect Server version 8.2 or later
  • Some features may not be enabled in all Adobe Connect meetings if one is using an Adobe Connect Server older than version 9.4.2 (required for Custom pods)
  • Google Android 4.4 or later
  • Apple iOS: iOS 8.1.2 or later
DSL/cable (wired connection recommended)

There is no fee for this activity. To receive credit, participants must register, view the live CME/CE activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.

If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.

Jointly provided by Boston University School, the Potomac Center for Medical Education and Rockpointe

In collaboration with

This program is supported by an educational grant from Daiichi Sankyo.

Rockpointe Privacy Policy